Related Experiment Video
Updated: Jun 22, 2026
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
[Review of 32 gastro-intestinal stromal tumours with CD117 antigen]
Ahlem Lahmar-Boufaroua1, Sana Ben Slama, Saadia Bouraoui
1Service d'Anatomie Pathologique, Hôpital Mongi Slim, La Marsa, Tunisie.
Aim:
The aim of this study is to review clinical data, histological and immunohistochemical findings and prognosis of stromal gastrointestinal tumors.
Methods:
A retrospective Study of 32 cases of stromal gastrointestinal tumors diagnosed in the Department of Pathology of Mongi Slim Hospital of Tunis from 1991 to 2004.
Results:
The average age of the patients was of 54.4 years, equal for sex. Tumors were essentially gastric (50%) and of the small intestine (37.5%). All the patients had surgical treatment. Gastro-intestinal Stromal Tumors or GIST represent the most frequent stromal tumor with 56.2% of cases.
Conclusion:
After immunohistochimestry study, using CD117 antigen, this revision allows better management of GIST. Glivec is the standard treatment of advanced GIST.
